Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cells Production Market Size, Share & Trends Analysis Report By Process, By Workflow (Cell Culture), By Product, By Application (Regenerative Medicine), By End-user, By Region, And Segment Forecasts, 2022 - 2030" study has been added to ResearchAndMarkets.com's offering.
The planetary induced pluripotent stem cells accumulation marketplace size is estimated to scope USD 2.8 cardinal by 2030. The marketplace is expected to grow astatine a CAGR of 9.2% from 2022 to 2030. The summation successful request for induced pluripotent stem cells (iPSCs) successful examination to Embryonic Stem Cells (ESCs) has offered a important thrust to the market.
Advantages specified arsenic nary stem cell-related ethical issues, personalized treatment, and flexibility during cell-based probe person created a favorable script for marketplace growth. In addition, the prevalence of chronic disorders is besides driving the maturation of the induced pluripotent stem cells accumulation market, arsenic conditions similar bosom disease, stroke, diabetes, and galore much tin beryllium treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 cardinal radical are already surviving with diabetes successful 2021.
The rising probe activities during COVID-19 pandemic person positively impacted the market. The pandemic fueled probe successful galore fields arsenic the SARS CoV-2 corruption resulted successful galore diseases successful the patients. For instance, successful April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their probe article, they demonstrated the pathogenesis via vulnerability of iPSCs-derived cardiac cells to SARS CoV-2, and akin alterations were confirmed from quality autopsy specimens of the patients. Such insights let the usage of induced pluripotent stem cells (iPSCs) arsenic cause oregon therapy improvement platforms and their utilization successful the absorption of the semipermanent effects of COVID-19.
Induced pluripotent stem cells are cells that are derived from big somatic cells and past further reprogrammed to get the pluripotency arsenic that of ESCs. These iPSCs are proving to beryllium an ethically uncomplicated alternate for probe that involves ESCs. The derivation of the ESCs is associated with the demolition of an embryo astatine the blastocyte stage, which has led to a maximum fig of ethical debates. However, induced pluripotent stem cells person solved the ethical contented implicit the demolition of quality embryos successful probe by involving lone the familial reprogramming of somatic cells.
This has propelled the marketplace maturation and resulted successful galore applications including cause discovery, illness modeling, toxicology testing, and galore others.
For instance, successful August 2021, Fate Therapeutics announced the attraction of the archetypal diligent with FT819 during objective trials. FT819 is an engineered CAR-T compartment therapy that is derived from iPSCs.
Also, the rising absorption of the probe assemblage connected exploring applications of induced pluripotent stem cells successful regenerative medicine owed to their unsocial characteristics specified arsenic differential potential, self-renewable, immunomodulatory properties, and others; is acceptable to thrust the marketplace expansion.
Induced Pluripotent Stem Cells Production Market Report Highlights
- By process, the manual iPSCs accumulation process held the highest marketplace stock successful 2021. The aggregate stages progressive during the manufacturing process and cardinal companies providing the expertise for induced pluripotent stem compartment accumulation attributes to the growth
- By workflow, successful 2021, the compartment civilization was the highest revenue-generating segment. As compartment civilization is simply a pivotal measurement successful the accumulation process and the associated costs during galore steps thrust the marketplace maturation of this segment
- By product, the consumables & kits conception held the largest marketplace successful 2021. The continuous usage of these iPSCs products during assorted applications specified arsenic toxicology investigating is propelling the segment's growth
- By application, cause improvement and find dominated the induced pluripotent stem cells accumulation marketspace successful 2021. The prevalence of chronic diseases is driving the summation successful innovative cause platforms for improvement & find by utilizing iPSCs arsenic diseased models
- By end-user, the biotechnology and pharmaceutical companies generated the highest gross successful the marketplace during 2021. The rising fig of strategical initiatives, caller merchandise launches, and robust iPSCs merchandise pipeline is attributing to the procreation of revenue
- North America portion contributes to the largest stock successful 2021 for iPSCs accumulation marketplace. The cardinal factors driving the gross maturation are the developed healthcare infrastructure, the prevalence of chronic diseases, the beingness of strategical concern models and funds by supportive government
Market Dynamics
Market Drivers
- Increase In Demand For IPSCs Over Embryonic Stem Cells
- Rise In The Integration Of Automation In Ipsc Production
- Expanding Exploitation Of Ipscs In Research
Market Restraints
- Lack Of Standardized & Regulated Delivery Of Stem Cells Therapy
- Scalable Manufacturing Of Ipscs
Market Opportunities
- Robust Pipeline For IPSCs
- Use Of IPSCs In Regenerative Medicine
| Report Attribute | Details |
| No. of Pages | 200 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) successful 2022 | $1367.6 Million |
| Forecasted Market Value (USD) by 2030 | $2800 Million |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Methodology And Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends, & Scope
Chapter 4 Induced Pluripotent Stem Cells (Ipscs) Production Market: Process Business Analysis
Chapter 5 Induced Pluripotent Stem Cells (Ipscs) Production Market: Workflow Business Analysis
Chapter 6 Induced Pluripotent Stem Cells (Ipscs) Production Market: Product Business Analysis
Chapter 7 Induced Pluripotent Stem Cells (Ipscs) Production Market: Application Business Analysis
Chapter 8 Induced Pluripotent Stem Cells (Ipscs) Production Market: End-User Business Analysis
Chapter 9 Induced Pluripotent Stem Cells (Ipscs) Production Market: Regional Business Analysis
Chapter 10 Company Profile
Companies Mentioned
- Lonza
- Axol Biosciences Ltd.
- Evotec Se
- Hitachi Ltd.
- Reprocells Inc.
- Fate Therapeutics.
- Thermo Fisher Scientific, Inc.
- Merck Kgaa
- Stemcellsfactory Iii
- Osiris Therapeutics Inc.
- Applied Stemcells Inc.
For much accusation astir this study sojourn https://www.researchandmarkets.com/r/pyzl0b
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's starring root for planetary marketplace probe reports and marketplace data. We supply you with the latest information connected planetary and determination markets, cardinal industries, the apical companies, caller products and the latest trends.
English (US)